
Insciences Organisation
<img alt="" height="1" width="1" />
Roche's Avastin fails in prostate cancer study
Reuters
By Martin de Sa'Pinto and Ben Hirschler ZURICH/LONDON, March 12 (Reuters) - Roche Holding AG's (ROG.VX) Avastin did not help men with late stage prostate cancer live longer in a clinical trial, marking another setback for the Swiss group as it tries to ...
Avastin Misses Prostrate-Cancer GoalWall Street Journal
Roche's Avastin Fails to Meet Goal of Prostate StudyBusinessWeek
Roche: prostate cancer study didn't meet objectiveMarketWatch
RTT News -Insciences Organisation
all 30 news articles »
More...